Sensus Healthcare Inc. (SRTS)
SRTS trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1494891/000175392626000435/0001753926-26-000435-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | SRTS on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2016 |
| SEC CIK | 0001494891 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $27.5M |
| Net income | -$7.7M |
| Operating income | -$10.3M |
| Net margin | -28.1% |
| Operating margin | -37.5% |
| Revenue growth | -34.3% |
| Cash | $22.1M |
| Total assets | $53.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.4× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-13 |
| Cash and burn | $15.2M cash; operating cash flow -$1.7M a quarter. | Report 2026-06-30 |
| Shares outstanding | 16,462,059 (2026-11-10); 16,425,036 a year earlier; 16,382,404 three years earlier. | Cover page 2026-11-10 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Carr, Riggs & Ingram LLC, Palm Beach Gardens, Florida, United States; changed auditors 1 time in 24 months | 8-K 4.01 2026-01-20 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $729K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $2.3M | -$8.7M | -$3.1M | $15.2M | No debt tags | $17.5M | 10-Q 2026-08-14 |
| Q1 2026 2026-03-31 | $3.4M | -$2.6M | -$3.8M | $18.3M | No debt tags | $22.5M | 10-Q 2026-05-13 |
| Q4 2025 2025-12-31 | $4.9M | -$3.2M | -$2.2M | $22.1M | No debt tags | $27.5M | 10-K 2026-03-04 |
| Q3 2025 2025-09-30 | $6.9M | -$943K | $2.3M | $24.5M | No debt tags | $35.6M | 10-Q 2025-11-12 |
| Q2 2025 2025-06-30 | $7.3M | -$1.0M | $3.1M | $22.2M | No debt tags | $37.6M | 10-Q 2026-08-14 |
| Q1 2025 2025-03-31 | $8.3M | -$2.6M | -$2.7M | $19.1M | No debt tags | $39.5M | 10-Q 2026-05-13 |
| Q4 2024 2024-12-31 | $13.1M | $1.5M | -$827K | $22.1M | No debt tags | $41.8M | 10-K 2026-03-04 |
| Q3 2024 2024-09-30 | $8.8M | $1.2M | $4.0M | $22.6M | No debt tags | $41.3M | 10-Q 2025-11-12 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2019-06-04 |
| Latest annual report | 10-K | 2026-03-04 |
| Latest quarterly / interim | 10-Q | 2026-11-13 |
| Latest current report | 8-K | 2026-11-12 |
| Latest proxy | DEF 14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 409 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -18.7% |
| 1 month | -19.6% |
| 3 months | -26.4% |
| Year to date | -41.6% |
| 1 year | -47.9% |
| From 52-week high | -56.1% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MDAI | Spectral AI Inc. | $1.31 | +0.77% | $42.2M |
| TELA | TELA Bio Inc. | $0.7616 | -7.13% | $34.4M |
| MBOT | Microbot Medical Inc. | $0.6444 | -34.16% | $43.3M |
| ADGM | Adagio Medical Holdings Inc | $1.61 | -16.58% | $44.2M |
| NEPH | Nephros Inc. | $3.00 | -1.64% | $32.6M |
| DXR | Daxor Corporation | $8.36 | -0.89% | $48.8M |
| XTNT | Xtant Medical Holdings Inc. | $0.2098 | -22.78% | $29.4M |
| NSPR | InspireMD Inc. | $0.6000 | -6.85% | $28.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier